Al Mayadeen English

  • Ar
  • Es
  • x
Al Mayadeen English

Slogan

  • News
    • Politics
    • Economy
    • Sports
    • Arts&Culture
    • Health
    • Miscellaneous
    • Technology
    • Environment
  • Articles
    • Opinion
    • Analysis
    • Blog
    • Features
  • Videos
    • NewsFeed
    • Video Features
    • Explainers
    • TV
    • Digital Series
  • Infographs
  • In Pictures
  • • LIVE
News
  • Politics
  • Economy
  • Sports
  • Arts&Culture
  • Health
  • Miscellaneous
  • Technology
  • Environment
Articles
  • Opinion
  • Analysis
  • Blog
  • Features
Videos
  • NewsFeed
  • Video Features
  • Explainers
  • TV
  • Digital Series
Infographs
In Pictures
  • Africa
  • Asia
  • Asia-Pacific
  • Europe
  • Latin America
  • MENA
  • Palestine
  • US & Canada
BREAKING
Iran's Fars News Agency: Nojeh Air Base in Hamadan was subjected to two Israeli missile attacks.
The Leader of the Revolution, Sayyed Ali Khamenei, issues a decree appointing Brigadier General Majid Mousavi as commander of the IRGC Aerospace Force.
Al Mayadeen's correspondent: Israeli attacks targeted four areas in Tabriz today
Tasnim News Agency: Air defenses in western Iran confront Israeli aggression targeting cities of Tabriz, Khorramabad, and Kermanshah
In its statement, the Army warns against engaging with unofficial statements circulating on social media platforms.
The Iranian Army confirms in a statement that it has no social media platform.
Spokesman for the Atomic Energy Organization of Iran: We moved important equipment out of the Fordow nuclear plant before the attack
"Israel's" Ichilov Hospital confirms recieving 52 wounded from Iranian missile strikes
Iranian TV: Iranian drones penetrated occupied Palestinian airspace and successfully struck several targets
Al Mayadeen's correspondent in Tehran: Iranian Arash drones launched toward Israeli targets in occupied Palestine

How is the door open for cheaper tuberculosis drugs in India?

  • By Al Mayadeen English
  • Source: Agencies
  • 29 Mar 2023 13:05
2 Min Read

Johnson & Johnson's bedaquiline extension is rejected by India's patent authorities, paving the way for generic equivalents.

  • x
  • =A relative adjusts the oxygen mask of a tuberculosis patient at a TB hospital on World Tuberculosis Day in Hyderabad, India. (AP)
    A relative adjusts the oxygen mask of a tuberculosis patient at a TB hospital on World Tuberculosis Day in Hyderabad, India. (AP)

Since the government denied US pharmaceutical firm Johnson & Johnson's request to extend a patent, people in India with drug-resistant tuberculosis may soon have access to life-saving treatment at a far reduced cost.

Bedaquiline's patent expires in July, but the company sought to extend it until 2027, which would have stopped less expensive generic versions from entering the market.

It was viewed as a success for two ladies who had been campaigning to lower the cost of a disease-treating medication for everyone. The medical Group Médecins Sans Frontières backed a case filed in 2019 by South Africans Phumeza Tisle and Nandita Venkatesan to the Indian Patent Office to block Johnson & Johnson's application (MSF).

The patent office's ruling opens the door for other businesses to create accessible versions. According to some health experts, this may reduce treatment costs from $46 (£37) per patient per month to $8 (£6.50) per patient per month.

This development will benefit patients in areas where TB medications are obtained through the World Health Organization because India exports generic medications to numerous low-income nations.

The last option for people with advanced TB is bedaquiline. It has unpleasant side effects, like most treatments for drug-resistant TB, but when the FDA authorized it in 2012, it was the first new medication for the condition in 40 years.

Indian pharmaceutical firms have begun developing generic versions of the medication. Some have pre-qualified to become providers by providing data to the WHO. Versions are anticipated to debut as early as August.

It is worth noting that the prevalence of TB and drug-resistant TB is highest in India. Each day, more than 1,000 Indians pass away from the illness.

Five years ahead of the 2030 worldwide deadline, India's goal is to eradicate TB by 2025.

The Indian government purchased bedaquiline for its TB program, and it is accessible in the majority of TB clinics in major cities but not in smaller towns or rural areas.

  • cheaper drugs
  • India
  • Big Pharma
  • Medicine

Most Read

The logo of the Iranian Ministry of Intelligence (wikidata)

Iran acquired thousands of sensitive Israeli documents: Exclusive

  • Politics
  • 7 Jun 2025
Iranian missiles impact Israeli sites in Tel Aviv in 2nd wave

Iran's missiles impact 'strategic' Israeli site in Tel Aviv

  • Politics
  • Today
'Israel' launches major strike against Iran's nuclear program

'Israel' launches massive aggression on Iran

  • MENA
  • 13 Jun 2025
Smoke rises after an Iranian ballistic missile directly struck Tel Aviv, Occupied Palestine, June 13, 2025 (AP)

Op. True Promise 3: Iran's ballistic missiles strike Tel Aviv

  • MENA
  • 13 Jun 2025

Coverage

All
War on Gaza

Read Next

All
Global condemnations mount against Israeli aggression on Iran
Politics

Global condemnations pour in against Israeli aggression on Iran

President Donald Trump attends the UFC 316 mixed martial arts event Saturday, June 7, 2025, in Newark, New Jersey (AP)
MENA

US denies role in attacks on Iran, yet vows to defend 'Israel'

Vehicles drive past an anti-Israeli banner showing missiles being launched, in a square in downtown Tehran, Iran, Friday, April 19, 2024. (AP)
Politics

Political, military Iranian figures vow revenge, slam US complicity

AEOI condemns IAEA silence after Israeli aggression on nuclear site
Politics

AEOI slams IAEA's silence despite Israeli aggression on nuclear site

Al Mayadeen English

Al Mayadeen is an Arab Independent Media Satellite Channel.

All Rights Reserved

  • x
  • Privacy Policy
  • About Us
  • Contact Us
  • Authors
Android
iOS